Certain criteria may be better than others in RA assessment

June 19, 2017

(HealthDay)—For patients with rheumatoid arthritis (RA), the performances of the Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than that of the Disease Assessment Score of 28 joints—C-reactive protein (DAS-28-CRP), according to a study published online June 12 in the International Journal of Rheumatic Diseases.

Pooja Dhaon, M.D., from Hind Institute of Medical Sciences in Safedabad, India, and colleagues included 135 patients with RA in a prospective study. The authors assessed at baseline and every six weeks for 24 weeks by DAS-28-CRP, CDAI, and SDAI. Based on pre-defined cut-offs, patients were classified into groups of remission, low , moderate activity, and high activity.

The researchers found that at baseline there was an excellent positive correlation between DAS-28-CRP and both CDAI (linear weighted κ, 0.545) and SDAI (linear weighted κ, 0.689). At the final visit there was moderate agreement between DAS-28-CRP and CDAI (linear weighted κ, 0.458) and between SDAI and DAS-28-CRP (linear weighted κ, 0.470). At baseline and the final visit, the correlation between CDAI and SDAI remained excellent. Significantly more residual disease activity was seen for patients in remission as per DAS-28-CRP versus SDAI and CDAI remission criteria.

"SDAI- and CDAI-based remission criteria seem to be better than DAS-28-CRP-based remission criteria," the authors write.

Explore further: ACR endorses standardized measures to determine rheumatoid arthritis disease activity

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

ACR endorses standardized measures to determine rheumatoid arthritis disease activity

April 2, 2012
A working group convened by the American College of Rheumatology (ACR) has evaluated more than 60 disease activity measures for rheumatoid arthritis (RA). The group narrowed the number of RA disease activity measures and ...

Ultrasound model IDs residual joint inflammation in RA

April 18, 2013
(HealthDay)—A model including ultrasound (US) assessment of the wrist, metacarpophalangeal (MCP), ankle, and metatarsophalangeal (MTP) joints is highly sensitive for detecting B-mode and Doppler joint inflammation in patients ...

Active synovitis with osteitis predicts residual synovitis in RA

February 8, 2017
(HealthDay)—For patients with rheumatoid arthritis (RA) who have clinical response to treatment, active synovitis with osteitis is associated with subsequent residual synovitis (R-synovitis), according to a study published ...

Doctors and rheumatoid arthritis patients differ on perception of disease activity

July 18, 2012
Researchers from Austria have determined that patients with rheumatoid arthritis (RA) and their doctors differ on perception of RA disease activity. The study now available in Arthritis & Rheumatism, a journal of the American ...

Smoking negatively affects response to anti-TNF treatment in patients with rheumatoid arthritis

June 8, 2012
A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, reinforces current thinking that smoking negatively affects treatment response in rheumatoid arthritis (RA) patients ...

Recommended for you

Study shows prevalence of knee osteoarthritis has doubled since World War II

August 14, 2017
The average American today is twice as likely to be diagnosed with knee osteoarthritis than in the years before World War II, Harvard scientists say, but that increase can't be blamed on the reasons most might think.

Researchers find arthritis drug could treat blood cancer patients

August 3, 2017
Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

Fluid in the knee holds clues for why osteoarthritis is more common in females

June 26, 2017
Researchers have more evidence that males and females are different, this time in the fluid that helps protect the cartilage in their knee joints.

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Drug for refractory psoriatic arthritis shows promise in clinical trial

May 24, 2017
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced ...

Cross-species links identified for osteoarthritis

May 17, 2017
New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.